EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold

Laura Braconi iD, Chiara Riganti iD, Astrid Parenti iD, Marta Cecchi iD, Alessio Nocentini iD, Gianluca Bartolucci iD, Marta Menicatti, Marialessandra Contino iD, Nicola Antonio Colabufo, Dina Manetti iD, Maria Novella Romanelli iD, Claudiu T Supuran iD und 1 weitere

Molecules · 2024

DOI: 10.3390/molecules29143290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Laura Braconi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence,…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Drug Resistance, Multiple, ATP Binding Cassette Transporter, Subfamily B, Member 1, Piperazines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Florence, Compagnia di San Paolo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new series of piperazine derivatives were synthesized and studied with the aim of obtaining dual inhibitors of P-glycoprotein (P-gp) and carbonic anhydrase XII (hCA XII) to synergistically overcome the P-gp-mediated multidrug resistance (MDR) in cancer cells expressing the two proteins, P-gp and hCA XII. Indeed, these hybrid compounds contain both P-gp and hCA XII binding groups on the two nitrogen atoms of the heterocyclic ring. All compounds showed good inhibitory activity on each protein (P-gp and hCA XII) studied individually, and many of them showed a synergistic effect in the resistant HT29/DOX and A549/DOX cell lines which overexpress both the target proteins. In particular, compound 33 displayed the best activity by enhancing the cytotoxicity and intracellular accumulation of doxorubicin in HT29/DOX and A549/DOX cells, thus resulting as promising P-gp-mediated MDR reverser with a synergistic mechanism. Furthermore, compounds 13, 27 and 32 induced collateral sensitivity (CS) in MDR cells, as they were more cytotoxic in resistant cells than in the sensitive ones; their CS mechanisms were extensively investigated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmDrug Resistance, MultipleATP Binding Cassette Transporter, Subfamily B, Member 1PiperazinesCarbonic Anhydrase InhibitorsCarbonic AnhydrasesHumansDoxorubicinPiperazineAntineoplastic AgentsHT29 CellsStructure-Activity RelationshipCell Line, TumorMolecular StructureA549 Cells

Stichwörter der Autor:innen

A549/DOXCA XII inhibitorsHT29/DOXK562/DOXMDR reversersP-gp modulatorsdual P-gp/CA XII inhibitory activityhybrid compoundsmultitarget ligandsselective chemosensitizers

Substanzen

carbonic anhydrase XIIATP Binding Cassette Transporter, Subfamily B, Member 1PiperazinesCarbonic Anhydrase InhibitorsCarbonic AnhydrasesDoxorubicinPiperazineAntineoplastic Agents

Autor:innen und Institutionen

  • Section of Pharmaceutical and Nutraceutical Sciences, Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy.
  • Oncological Pharmacology Laboratory and Molecular Biotechnology Center "Guido Tarone", Department of Oncology, University of Turin, Piazza Nizza 44, 10126 Torino, Italy.
  • Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy.
  • Section of Pharmacology and Toxicology, Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy.
  • Department of Pharmacy-Drug Sciences, University of Bari "A. Moro", via Orabona 4, 70125 Bari, Italy.

ORCID-Profile: Laura Braconi, Chiara Riganti, Astrid Parenti, Marta Cecchi, Alessio Nocentini, Gianluca Bartolucci, Marialessandra Contino, Dina Manetti, Maria Novella Romanelli, Claudiu T Supuran, Elisabetta Teodori

Förderung

  • University of Florence
  • Compagnia di San Paolo

Zitieren

APA

Braconi, L., Riganti, C., Parenti, A., Cecchi, M., Nocentini, A., Bartolucci, G., Menicatti, M., Contino, M., Colabufo, N. A., Manetti, D., Romanelli, M. N., Supuran, C. T., & Teodori, E. (2024). Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold. Molecules. https://doi.org/10.3390/molecules29143290

Vancouver

Braconi L, Riganti C, Parenti A, Cecchi M, Nocentini A, Bartolucci G, et al. Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold. Molecules. 2024. doi:10.3390/molecules29143290

BibTeX
@article{Braconi2024,
  author = {Braconi, Laura and Riganti, Chiara and Parenti, Astrid and Cecchi, Marta and Nocentini, Alessio and Bartolucci, Gianluca and Menicatti, Marta and Contino, Marialessandra and Colabufo, Nicola Antonio and Manetti, Dina and Romanelli, Maria Novella and Supuran, Claudiu T and Teodori, Elisabetta},
  title = {Dual Inhibitors of P-gp and Carbonic Anhydrase XII (hCA XII) against Tumor Multidrug Resistance with Piperazine Scaffold},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29143290}
}
Kostenlos starten →